Prima Sung

Sr. Product Marketing Manager at Elsevier

Connect with Prima Sung on LinkedIn
Website: https://www.elsevier.com

About the author:

Prima has extensive experience in the information technology industry. Her role involves defining value propositions through immersive understanding of the industry and users of information solutions. Prior to joining Elsevier, Prima worked at Microsoft and Nokia on designing solutions for the future of mobile computing. She holds an MBA from Hofstra University in New York, USA.

Posts by Prima Sung

The Power of Two in Lead Optimization

Posted on July 3rd, 2017 in Chemistry

The rise of in silico approaches has revolutionized early drug discovery, making it possible to model the potential in vivo behaviors of large numbers of compounds, delve deep into their bioactive and chemical properties, Continue reading “The Power of Two in Lead Optimization” »

Leveling the Playing Field in Medicinal Chemistry

Posted on June 26th, 2017 in Chemistry

For the designers and developers of Elsevier’s R&D Solutions, a major concern is ensuring that each solution makes the same level of searching or analytical power available to all users. The primary aim for the teams is to Continue reading “Leveling the Playing Field in Medicinal Chemistry” »

New Reaxys: A Model of Agile Development

Posted on April 11th, 2017 in Chemistry

The development of a chemistry research solution is not something that should occur solely in the IT department of the product owner. Without the participation of the intended end users of the product, how can the developers be sure that they’re addressing real needs? Continue reading “New Reaxys: A Model of Agile Development” »

Lessons Learned from a Clinical Trial Failure

Posted on March 14th, 2017 in Chemistry

Revisiting failed clinical trials is important because these studies may generate new insights into drug research and development, leading to effective new treatments. Researchers in the recent IMPROVE-IT trial learned valuable lessons from the failure of the earlier ENHANCE study Continue reading “Lessons Learned from a Clinical Trial Failure” »